Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

NTT Docomo (DCM) a Buy on Robust Quant Score

By Portfolio Grader
The current recommendation of Buy for NTT Docomo Inc (NYSE:DCM) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. DCM has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Bitcoin Price Surpasses $6,000 — the Blockchain Bubble Is Here

By Dana Blankenhorn, InvestorPlace Contributor
Blockchain can't handle trading volumes that would make it a currency. Yet a fork won't happen because it threatens bitcoin's value.

DowDuPont (DWDP) a Buy on Strong Sales Growth

By Portfolio Grader
Currently, DowDuPont Inc (NULL:DWDP) has a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. This represents no change from the previous week and is the same ranking DWDP has had from Portfolio Grader for the last month.

Quant Score Restricts AstraZeneca (AZN) Rating

By Portfolio Grader
AstraZeneca Plc (NYSE:AZN) is a component of the 135 company Pharmaceuticals GICS industry group, which is a segment of the 783 company GICS Health Care sector. AZN's market value is $87.6 billion which falls in the top decile in its industry group. The ranking for AZN by Portfolio Grader places it 49 among the 135 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 301 among the 783 companies in the sector, and number 2,076 in the nearly 5,000 company Portfolio Grader universe.

Procter & Gamble Co (PG) Stock Slides on Disappointing Sales

By William White, InvestorPlace Writer
Procter & Gamble (PG) stock took a hit today after the company reported weak sales during its fiscal first quarter of 2018.

International Business Machines Corp. Stock Is Soaring Post-Earnings, But Can This Rally Last?

By Josh Enomoto, InvestorPlace Contributor
The IBM stock price received a massive boost following its Q3 earnings report, but can IBM ride the tailwind?

Analytics for Quant Score Makes Schlumberger (SLB) a Sell

By Portfolio Grader
Schlumberger NV (NYSE:SLB) is ranked as a Sell using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. SLB has maintained this ranking for 3 months.

Earnings Visibility Makes Novo Nordisk A/S (NVO) a Buy

By Portfolio Grader
Novo Nordisk A/S (NYSE:NVO) is a $93.3 billion in market value constituent of the Pharmaceuticals GICS industry group where Portfolio Grader's current ranking for NVO puts it 29 among the 135 companies in this industry group, giving it a well above-average position. NVO is ranked in the top half of the sector with a ranking of 203 among the 783 companies in the sector and number 1,464 in the 5000 company Portfolio Grader company universe.

General Electric Company (GE) Stock Smacked After Terrible Q3 Earnings

By William White, InvestorPlace Writer
General Electric (GE) stock was down on Friday following the release of a poor earnings report for the third quarter of 2017.

General Electric Company Is Having a Major Crisis, But Don’t Panic

By Dana Blankenhorn, InvestorPlace Contributor
General Electric was sold by former CEO Jeff Immelt as a technology company, but it wound up as an energy company. And GE earnings haven't helped its case.

Eli Lilly (LLY) a Hold on Anemic Earnings Momentum

By Portfolio Grader
Portfolio Grader currently ranks Eli Lilly and Company (NYSE:LLY) a Hold. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week. This represents no change from the previous week and is the same ranking LLY has had from Portfolio Grader for 7 months.

Improving Analytics Lift Ranking of GlaxoSmithKline (GSK) to Hold

By Portfolio Grader
GlaxoSmithKline Plc (NYSE:GSK) is ranked as a Hold using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. GSK has been upgraded from a Sell to a Hold in the last week.

Bristol-Myers Squibb Co (BMY) Ranking Raised to Buy on Superior Earnings Visibility

By Portfolio Grader
Bristol-Myers Squibb Co (NYSE:BMY) is a constituent of the 135 company Pharmaceuticals GICS industry group, which is part of the 783 company GICS Health Care sector. BMY's market value is $107.1 billion which falls in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 32 among the 135 companies in this industry group, giving it a well above-average position; in the top half of the sector with a ranking of 225 among the 783 companies in the sector, and number 1,631 in the nearly 5,000 company Portfolio Grader universe.

Will Ford Motor Company Stock Catch Up to General Motors?

By Bret Kenwell, InvestorPlace Contributor
Ford has largely missed the rally that General Motors has enjoyed. Will F stock perk up and finally play catch-up or continue to lag?

Sanofi (SNY) a Strong Buy on Outstanding Quant Score

By Portfolio Grader
Sanofi SA (NYSE:SNY) is classified as a member of the 135 company Pharmaceuticals GICS industry group, which is a segment of the 783 company GICS Health Care sector. SNY's market value is $124.3 billion which falls in the top decile in its industry group. The stock's current Portfolio Grader score places it 2 among the 135 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 18 among the 783 companies in the sector, and number 194 in the nearly 5,000 company Portfolio Grader universe.

Improving Quant Score Analytics Drive Ranking of BP (BP) to Buy

By Portfolio Grader
BP Plc (NYSE:BP) is ranked as a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Total’s (TOT) Superior Sales Growth Keeps it a Buy

By Portfolio Grader
Total SA (NYSE:TOT) is classified as a constituent of the 290 company Oil Gas & Consumable Fuels GICS industry group, which is part of the 362 company GICS Energy sector. The market value of TOT is $134.4 billion which places it in the top decile in its industry group. The stock's current Portfolio Grader score places it 23 among the 290 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 25 among the 362 companies in the sector, and number 900 in the nearly 5,000 company Portfolio Grader universe.

Superb Metrics for Sales Growth Make Royal Dutch Shell (RDS.A) a Strong Buy

By Portfolio Grader
Royal Dutch Shell Plc (NYSE:RDS.A) is a constituent of the 290 company Oil Gas & Consumable Fuels GICS industry group, which is part of the 362 company GICS Energy sector. RDS.A has a market value of $137.4 billion which is in the top 10% of its industry group. The stock's current Portfolio Grader score places it 8 among the 290 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 8 among the 362 companies in the sector, and number 322 in the nearly 5,000 company Portfolio Grader universe.

Quant Score Keeps Merck & Co (MRK) a Sell

By Portfolio Grader
The current recommendation of Sell for Merck & Co (NYSE:MRK) has been derived by using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methods. MRK has recently seen its Portfolio Grader rating downgraded over the last month from a Hold to a Sell.
Load More Articles